{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Horsham",
      "address_1": "425 Privet Rd",
      "reason_for_recall": "CGMP Deviations",
      "address_2": "",
      "product_quantity": "13,223 vials",
      "code_info": "All Lots Within Expiry  Lot # 2930614, 2940614, 2950614",
      "center_classification_date": "20160907",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "state": "PA",
      "product_description": "Ondansetron Injection USP 40 mg/20 mL (2 mg/mL), Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454  NDC # 0703-7226-01 (20 mL- Multi-dose Vial), NDC # 0703-72263-03 (10 Multi-dose Vials per carton)",
      "report_date": "20160914",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Teva North America",
      "recall_number": "D-1497-2016",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "74497",
      "termination_date": "20170207",
      "more_code_info": "",
      "recall_initiation_date": "20160617",
      "postal_code": "19044-1220",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}